These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16011728)

  • 21. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic resistance of Helicobacter pylori].
    Wang F; Shen SR; Zhou JD; Xu CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New guidelines for Helicobacter pylori: applying them to your practice.
    Nimish V
    Rev Gastroenterol Disord; 2007; 7(3):111-4. PubMed ID: 17928790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
    Nijevitch AA; Shcherbakov PL; Sataev VU; Khasanov RSh; Al Khashash R; Tuygunov MM
    Aliment Pharmacol Ther; 2005 Nov; 22(9):881-7. PubMed ID: 16225499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
    Qasim A; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Helicobacter pylori infection 2010.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
    Lochmannová J
    Klin Mikrobiol Infekc Lek; 2010 Dec; 16(6):199-202. PubMed ID: 21243598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori: testing and treatment.
    Talley NJ; Li Z
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):71-9. PubMed ID: 19072436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori treatment in the era of increasing antibiotic resistance.
    Graham DY; Fischbach L
    Gut; 2010 Aug; 59(8):1143-53. PubMed ID: 20525969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.
    Lee YC; Wu HM; Chen TH; Liu TY; Chiu HM; Chang CC; Wang HP; Wu MS; Chiang H; Wu MC; Lin JT
    Helicobacter; 2006 Oct; 11(5):418-24. PubMed ID: 16961802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori diagnosis and management.
    Vilaichone RK; Mahachai V; Graham DY
    Gastroenterol Clin North Am; 2006 Jun; 35(2):229-47. PubMed ID: 16880064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-week versus two-week furazolidone-based quadruple therapy as the first-line treatment for Helicobacter pylori infection in Iran.
    Daghaghzadeh H; Emami MH; Karimi S; Raeisi M
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1399-403. PubMed ID: 17645463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2012 Jan; 35(2):209-21. PubMed ID: 22129228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.